Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Ascendis Pharma A/S publishes a filing, an earnings call transcript or a press release.

Get ASND alerts

About Scott Smith

Scott Smith is recorded as CFO at Ascendis Pharma A/S (ASND). Scott Smith has spoken on 22 earnings calls and 1 other investor event across 1 company, most recently for Ascendis Pharma A/S on September 15, 2026. Ascendis Pharma A/S is classified in the Biotechnology industry within the Healthcare sector.

Scott Smith on recent calls

“As Ian mentioned, we announced a $400 million share repurchase agreement, and that's really on the back of the strength of the financial transformation that happened with Ascendas this year in 2026, going from historically R&D to having approval and launch of three highly differentiated products. with Yorva Path…”
CFO, Morgan Stanley 24th Annual Global Healthcare Conference ·
“I will touch on some key points surrounding our second quarter financial results.”
CFO, Q2 2026 Ascendis Pharma Earnings Conference Call ·
“I will touch on some key points surrounding our first quarter financial results, which reinforce our confidence for growing operating profit and cash flow into the future.”
CFO, Ascendis Pharma A/S Q1 FY2026 Earnings Call ·
“Thank you so much, Operator and thank you everyone for joining our first quarter 2025 financial results conference call. I’m Scott Smith, Chief Financial Officer at Ascendis Pharma.”
CFO, Ascendis Pharma A/S Q1 FY2025 Earnings Call ·
“And thank you everyone for joining our full year 2024 financial results conference call. I’m Scott Smith, Chief Financial Officer at Ascendis Pharma.”
CFO, Ascendis Pharma A/S Q4 FY2024 Earnings Call ·

Affiliation history

Company network

Recent activity

Show 11 earlier activities